Could Bayer's non-hormonal elinzanetant signal the end of menopausal hot flashes?
Bayer announced today (May 17) that it will showcase its results of two phase 3 studies that could combat hot flashes for menopausal women.
Archives for May 17, 2024
News & Analysis on Clinical Trial Services & Contract Research And Development
- Home
- APIs (active pharmaceutical ingredients)
- Delivery formulations
- Delivery technologies
- Excipients, raw materials & intermediates
- Processing equipment
- QA/QC
- Regulations
- Tabletting, coating & ancillary equipment
- Analytical testing, QC
- Bulk ingredients
- Contract Manufacturing
- Contract sales & marketing
- Data management
- Drug delivery, formulation
- Fill & finish, packaging
- Medical Devices
- Phase I-II
- Phase III-IV
- Preclinical
- Regulatory affairs
- Supply chain, logistics
- Validation services
- Suppliers